Chemical Stem Cell Signature Predicts Treatment Response for Acute Myeloid Leukemia

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews